« Back to Record
Citation APA

Ribrag, V., Tilly, H., Casasnovas, O., Bosly, A., Bouabdallah, R., Delarue, R., Boue, F., Bron, D., Feugier, P., Haioun, C., Offner, F., & Coiffier, B. (2013). Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). European journal of cancer, 49(4), 904-910. doi:10.1016/j.ejca.2012.11.015


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168066

Ribrag, V., Tilly, H., Casasnovas, O., Bosly, A., Bouabdallah, R., Delarue, R., Boue, F., Bron, D., Feugier, P., Haioun, C., Offner, F., & Coiffier, B. (2013). Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA). European journal of cancer, 49(4), 904-910. doi:10.1016/j.ejca.2012.11.015